Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
190A Chordia Therapeutics
- 316
- -1-0.32%
20min DelayMarket Closed Dec 30 15:30 JST
21.55BMarket Cap-10.16P/E (Static)
332High313Low5.92MVolume316Open317Pre Close1.91BTurnover93052wk High27.72%Turnover Ratio68.21MShares14252wk Low-31.11EPS TTM6.75BFloat Cap930Historical HighLossP/E (Static)21.35MShs Float142Historical Low-31.11EPS LYR5.99%Amplitude--Dividend TTM5.17P/B100Lot Size--Div YieldTTM
About Chordia Therapeutics Company
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
Company Profile
Symbol190A
Company NameChordia Therapeutics
Founded2017-10-12
MarketTSE Growth
Fiscal Year Ends08-31
Address2-26-1 Muraoka-Higashi Kanagawa
Zip Code251-0012
Phone03-6661-9543
Company Executives
- Name
- Position
- Salary
- Hiroshi Miyake
- Representative Director
- --
- Yukari Nishikata
- Independent Director
- --
- Satoshi Nakamura
- Independent Director
- --
- Kosuke Ishii
- Independent Director
- --
- Ayuko Hashimoto
- Independent Director
- --
- Akihiko Shimauchi
- Independent Director
- --